cyc 202 has been researched along with zd 9331 in 1 studies
Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (zd 9331) | Trials (zd 9331) | Recent Studies (post-2010) (zd 9331) |
---|---|---|---|---|---|
979 | 7 | 393 | 55 | 17 | 2 |
Protein | Taxonomy | cyc 202 (IC50) | zd 9331 (IC50) |
---|---|---|---|
Thymidylate synthase | Mus musculus (house mouse) | 0.0014 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doyle, B; Geller, JI; Houghton, JA; Petak, I; Szekely-Szucs, K | 1 |
1 other study(ies) available for cyc 202 and zd 9331
Article | Year |
---|---|
P21Cip1 is a critical mediator of the cytotoxic action of thymidylate synthase inhibitors in colorectal carcinoma cells.
Topics: Apoptosis; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Synergism; Enzyme Inhibitors; fas Receptor; G1 Phase; HCT116 Cells; HT29 Cells; Humans; Interferon-gamma; Purines; Quinazolines; Roscovitine; S Phase; Thymidylate Synthase | 2004 |